Literature DB >> 21295892

Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes.

Ke-Jie Du1, Jin-Quan Wang, Jun-Feng Kou, Guan-Ying Li, Li-Li Wang, Hui Chao, Liang-Nian Ji.   

Abstract

Two ruthenium(II) complexes [Ru(bpy)(2)(bfipH)](2+) (1) and [Ru(phen)(2)(bfipH)](2+) (2) have been synthesized and characterized. The DNA-binding behaviors of complexes were studied by using spectroscopic and viscosity measurements. Results suggested that the two complexes bind to DNA in an intercalative mode. Complexes 1 and 2 can efficiently photocleave pBR322 DNA in vitro under irradiation, singlet oxygen ((1)O(2)) was proved to contribute to the DNA photocleavage process. Topoisomerase inhibition and DNA strand passage assay confirmed that two Ru(II) complexes acted as efficient dual inhibitors of topoisomerases I and II. In MTT cytotoxicity studies, two Ru(II) complexes exhibited antitumor activity against BEL-7402, HeLa, MCF-7 tumor cells. The AO/EB staining assay indicated that Ru(II) complexes could induce the apoptosis of HeLa cells.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295892     DOI: 10.1016/j.ejmech.2011.01.019

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.

Authors:  Petar Čanović; Ana Rilak Simović; Snežana Radisavljević; Ioannis Bratsos; Nicola Demitri; Marina Mitrović; Ivanka Zelen; Živadin D Bugarčić
Journal:  J Biol Inorg Chem       Date:  2017-07-10       Impact factor: 3.358

2.  Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.

Authors:  Jun-Feng Kou; Chen Qian; Jin-Quan Wang; Xiang Chen; Li-Li Wang; Hui Chao; Liang-Nian Ji
Journal:  J Biol Inorg Chem       Date:  2011-08-21       Impact factor: 3.358

3.  Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells.

Authors:  Jin-Quan Wang; Ping-Yu Zhang; Chen Qian; Xiao-Juan Hou; Liang-Nian Ji; Hui Chao
Journal:  J Biol Inorg Chem       Date:  2013-11-28       Impact factor: 3.358

4.  DNA Interaction, Photocleavage and Topoisomerase I Inhibition by Ru(II) Complex with a New Ligand Possessing Phenazine Unit.

Authors:  Xue-Wen Liu; You-Ming Shen; Jun-Shi Shu; Yang Xiao; Song-Bai Zhang; Ji-Lin Lu
Journal:  J Fluoresc       Date:  2015-08-19       Impact factor: 2.217

5.  Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cells.

Authors:  Aliny Pereira Lima; Flávia Castro Pereira; Marcio Aurelio Pinheiro Almeida; Francyelli Mariana Santos Mello; Wanessa Carvalho Pires; Thallita Monteiro Pinto; Flávia Karina Delella; Sérgio Luis Felisbino; Virtudes Moreno; Alzir Azevedo Batista; Elisângela de Paula Silveira-Lacerda
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

6.  The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.

Authors:  Lanmei Chen; Guodong Li; Fa Peng; Xinming Jie; Guangzhi Dongye; Kangrong Cai; Ruibing Feng; Baojun Li; Qingwang Zeng; Kaiyi Lun; Jincan Chen; Bilian Xu
Journal:  Oncotarget       Date:  2016-12-06

Review 7.  Applications of Ruthenium Complex in Tumor Diagnosis and Therapy.

Authors:  Ke Lin; Zi-Zhuo Zhao; Hua-Ben Bo; Xiao-Juan Hao; Jin-Quan Wang
Journal:  Front Pharmacol       Date:  2018-11-19       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.